Sarip, Haiba A.

HRN: 22 79 29  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/23/2025
05/29/2025
IV
1.5gm
Q6
Infected Wound
Waiting Final Action 
05/23/2025
MUPIROCIN 2%, 15G (TUBE)
05/23/2025
05/29/2025
TOPICAL
Apply Thin Coat
BID
Infected Wound
Waiting Final Action 
05/23/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/23/2025
05/25/2025
IV
600mg
Q6
Infected Wound
Waiting Final Action 
06/09/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/09/2025
06/16/2025
IV
4.5g
Q8h
Infected Wound Lumbosacral Area Bilateral
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: